Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9T0R

Crystal structure of SARS-CoV-2 Mpro in complex with GK729

This is a non-PDB format compatible entry.
Summary for 9T0R
Entry DOI10.2210/pdb9t0r/pdb
Descriptor3C-like proteinase nsp5, (phenylmethyl) ~{N}-[(2~{S})-1-[[(1~{S},2~{S})-1-[4-(1-methoxyethenyl)-1,3-thiazol-2-yl]-1-oxidanyl-3-[(3~{S})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]amino]-4-methyl-1-oxidanylidene-pentan-2-yl]carbamate (3 entities in total)
Functional Keywordsinhibitor, complex, viral protein
Biological sourceSevere acute respiratory syndrome coronavirus 2
Total number of polymer chains4
Total formula weight137480.84
Authors
El Kilani, H.,Hilgenfeld, R. (deposition date: 2025-10-20, release date: 2026-08-05)
Primary citationTheodoropoulou, M.A.,El Kilani, H.,Mantzourani, C.,Jochmans, D.,Neyts, J.,Zhang, K.,Roske, J.,Kokotou, M.G.,Hilgenfeld, R.,Kokotos, G.
Thiazolyl 4-carboxylate ketone as a new warhead for a highly potent SARS-CoV-2 main protease inhibitor.
Eur.J.Med.Chem., 303:118436-118436, 2026
Cited by
PubMed Abstract: The SARS-CoV-2 main protease (M), an enzyme essential for viral replication and lacking a human homologue, has emerged as a highly attractive target for the development of novel antiviral agents. Although several M inhibitors have been developed - some receiving regulatory approval - their use is sometimes limited by drug-drug interactions. In this study, we designed and synthesized peptidomimetic SARS-CoV-2 M inhibitors incorporating a novel thiazolyl 4-carboxylate ketone warhead, previously employed by our group in the development of cytosolic phospholipase A inhibitors. The synthesized compounds were evaluated for their in vitro inhibitory potency against SARS-CoV-2 M, and a highly potent M inhibitor (GK730) was identified (IC 5.75 nM). The melting temperature of the M-GK730 complex revealed high stability, consistent with the high inhibitory potency. The X-ray crystal structures of inhibitors GK729 and GK730 bound to M were determined, providing insights into the binding interactions and mechanism of action. Studies on the host cell proteases cathepsin B and L showed that GK730 did not inhibit cathepsin B, while exhibited weak inhibition of cathepsin L. Furthermore, GK730 demonstrated an EC value of 5.70 μM against a wild-type SARS-CoV-2 strain in Vero E6 cells and minimal cytotoxicity (CC value greater than 100 μM).
PubMed: 41344111
DOI: 10.1016/j.ejmech.2025.118436
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (1.55 Å)
Structure validation

258009

PDB entries from 2026-08-12

PDB statisticsPDBj update infoContact PDBjnumon